Author

Yuxin Wang

UC Davis Comprehensive Cancer CenterORCID 0000-0002-0305-9820Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yuxin Wang5 papers · Genesius Lab, Shanghai Innovation Institute, Shanghai 200231, China;

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Barbara I. Cerame· 1 shared Bruce D. HammockiD· 1 shared Bruno FèveiD· 1 shared Célia Moulin· 1 shared Christophe H.P. MorisseauiD· 1 shared Corinne VigourouxiD· 1 shared Émilie CapeliD· 1 shared Fabrizio AndréelliiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Barbara I. Cerame

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic & Genomic MedicineeLifePeer-reviewedAug 3, 2021

EPHX1 mutations cause a lipoatrophic diabetes syndrome due to impaired epoxide hydrolysis and increased cellular senescence

Jérémie Gautheron, Christophe H.P. Morisseau, Wendy K. Chung…·Isabelle Jéru

The paper identifies EPHX1 mutations causing lipoatrophic diabetes through impaired epoxide hydrolysis and increased cellular senescence, with metreleptin therapy showing benefit.

29 citations

humanexperimental assay

𝕏 PostBluesky